Clinical Trial

A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 4, 2024 (before its estimated February 27, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary purpose of this study is to evaluate the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy participants.
Trial Details
NCT Number NCT06627556
Lead Sponsor Jiangsu Carephar Pharmaceutical Co., Ltd.
Conditions Ulcerative Colitis
Enrollment 64 participants
Start Date 2024-09-17
Primary Completion 2025-02-27 (estimated)
Study Completion 2025-02-27 (estimated)
Updated on ClinicalTrials.gov 2024-10-04